Elevation Oncology Inc
NASDAQ:ELEV

Watchlist Manager
Elevation Oncology Inc Logo
Elevation Oncology Inc
NASDAQ:ELEV
Watchlist
Price: 0.365 USD -2.12%
Market Cap: 21.6m USD

Intrinsic Value

The intrinsic value of one ELEV stock under the Base Case scenario is 1.047 USD. Compared to the current market price of 0.365 USD, Elevation Oncology Inc is Undervalued by 65%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ELEV Intrinsic Value
1.047 USD
Undervaluation 65%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Elevation Oncology Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ELEV?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ELEV valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Elevation Oncology Inc.

Explain Valuation
Compare ELEV to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ELEV?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Elevation Oncology Inc

Current Assets 82.2m
Cash & Short-Term Investments 80.7m
Other Current Assets 1.5m
Non-Current Assets 29k
PP&E 29k
Efficiency

Free Cash Flow Analysis
Elevation Oncology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Elevation Oncology Inc

Revenue
0 USD
Operating Expenses
-45.7m USD
Operating Income
-45.7m USD
Other Expenses
-2.3m USD
Net Income
-48m USD
Fundamental Scores

ELEV Profitability Score
Profitability Due Diligence

Elevation Oncology Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
23/100
Profitability
Score

Elevation Oncology Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ELEV Solvency Score
Solvency Due Diligence

Elevation Oncology Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
45/100
Solvency
Score

Elevation Oncology Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ELEV Price Targets Summary
Elevation Oncology Inc

There are no price targets for ELEV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Elevation Oncology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ELEV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ELEV Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ELEV stock?

The intrinsic value of one ELEV stock under the Base Case scenario is 1.047 USD.

Is ELEV stock undervalued or overvalued?

Compared to the current market price of 0.365 USD, Elevation Oncology Inc is Undervalued by 65%.

Back to Top